SK3 Group, Inc. (SKTO)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jun 24, 2025
bluebird bio Revenue
In the year 2010, SK3 Group had annual revenue of $7.95M with 42.92% growth. SK3 Group had revenue of $4.99K in the quarter ending June 30, 2009.
Revenue
7.95M
Revenue Growth
+42.92%
P/S Ratio
0.00
Revenue / Employee
467.82K
Employees
17
Market Cap
1.24K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2010 | 7.95M | 2.39M | 42.92% |
| Dec 31, 2009 | 5.56M | 5.55M | 36,081.24% |
| Dec 31, 2008 | 15.38K | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |